Reply to: Expanding the Spectrum of Primary Cutaneous Carcinoma With BRD3-NUTM1 Fusion
Authors:
- 31 August 2021
- journal article
- letter
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 45 (11) , 1584-1586
Abstract
An abstract is unavailable. This article is available as a PDF only.Keywords
This publication has 5 references indexed in Scilit:
- NUT Is a Specific Immunohistochemical Marker for the Diagnosis of YAP1-NUTM1-rearranged Cutaneous Poroid NeoplasmsAmerican Journal of Surgical Pathology, 2021
- Utility of YAP1 and NUT immunohistochemistry in the diagnosis of porocarcinomaJournal of Cutaneous Pathology, 2020
- Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinomaJournal of Clinical Investigation, 2019
- NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatmentPathology International, 2018
- Diagnosis of NUT Midline Carcinoma Using a NUT-specific Monoclonal AntibodyAmerican Journal of Surgical Pathology, 2009